Sale!

AAAS Full Gene Sequence Analysis Allogrove Syndrome Test

7,250 د.إ

-10%

The AAAS Full Gene Sequence Analysis Allogrove Syndrome Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect Alagille Syndrome, a genetic disorder that can affect the liver, heart, and other parts of the body. This test specifically targets the AAAS gene, mutations in which are known to be a significant cause of this condition. By sequencing the entire gene, the test can identify both known and novel mutations, providing crucial information for accurate diagnosis and management of the syndrome.

Priced at 7250 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality standards and reliable results. This test is particularly important for individuals with a family history of Alagille Syndrome or those exhibiting symptoms related to the disease, as it can guide treatment decisions and inform about the risk of passing the condition to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AAAS Full Gene Sequence Analysis Allogrove Syndrome Test

Components: Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer (2ml)

Price: 7250.0 AED

Sample Condition: Peripheral blood/Amniotic Fluid/ Chorionic villi/ Cord blood

Report Delivery: 2-3 weeks

Method: Sanger Sequencing

Test type: Genetics

Doctor: Gynecologist

Test Department: Pre Test Information

AAAS Full Gene Sequence Analysis (Allogrove Syndrome) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

Allogrove Syndrome is a rare genetic disorder that affects the immune system. It is caused by mutations in the NFKB2 gene, which provides instructions for making a protein that is involved in the regulation of immune system function. The specific mutations that cause Allogrove Syndrome result in the production of a truncated or abnormal protein that disrupts normal immune system function.

People with Allogrove Syndrome may have recurrent infections, particularly of the respiratory and gastrointestinal tracts. They may also have autoimmune disorders, such as rheumatoid arthritis or lupus, and an increased risk of developing lymphoma.

Diagnosis of Allogrove Syndrome is typically made through genetic testing, which can identify the specific NFKB2 mutations. Treatment may involve antibiotics to manage infections, immunoglobulin replacement therapy to boost the immune system, and other supportive measures. Gene therapy and bone marrow transplantation may also be potential treatment options.

It is important to note that the information provided here is for educational purposes only and should not be used as a substitute for professional medical advice. If you have any concerns about your health or the health of a loved one, please consult a healthcare provider.

 

Test NameAAAS Full Gene Sequence Analysis Allogrove Syndrome Test
ComponentsSterile container/ Sterile Normal Saline Container/ EDTA Vacutainer (2ml)
Price7250.0 AED
Sample ConditionPeripheral blood\/Amniotic Fluid\/ Chorionic villi\/ Cord blood
Report Delivery2-3 weeks
MethodSanger Sequencing
Test typeGenetics
DoctorGynecologist
Test Department: 
Pre Test InformationAAAS Full Gene Sequence Analysis (Allogrove Syndrome) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Allogrove Syndrome is a rare genetic disorder that affects the immune system. It is caused by mutations in the NFKB2 gene, which provides instructions for making a protein that is involved in the regulation of immune system function. The specific mutations that cause Allogrove Syndrome result in the production of a truncated or abnormal protein that disrupts normal immune system function.

 

People with Allogrove Syndrome may have recurrent infections, particularly of the respiratory and gastrointestinal tracts. They may also have autoimmune disorders, such as rheumatoid arthritis or lupus, and an increased risk of developing lymphoma.

 

Diagnosis of Allogrove Syndrome is typically made through genetic testing, which can identify the specific NFKB2 mutations. Treatment may involve antibiotics to manage infections, immunoglobulin replacement therapy to boost the immune system, and other supportive measures. Gene therapy and bone marrow transplantation may also be potential treatment options.

 

It is important to note that the information provided here is for educational purposes only and should not be used as a substitute for professional medical advice. If you have any concerns about your health or the health of a loved one, please consult a healthcare provider.